Telemis, a specialist in medical imaging and business intelligence solutions for the healthcare sector, continues its robust growth.
Telemis, a specialist in medical imaging and business intelligence
solutions for the healthcare sector, continues its robust growth.
For the 2024-2025 fiscal year, Telemis achieved a turnover of €12,656,919 with a profit of €2,087,690, solidifying its twenty-third consecutive year of profitability. The group's revenue grew by 6%, while its after-tax profit saw a 41% increase. These figures underscore the strength of its strategy and the effectiveness of its teams.
Digital Pathology: In Full Boom
The digital pathology sector experienced exceptional growth this year. In France, TM-Microscopy was adopted by several cancer treatment centers and hospitals. Meanwhile, new deployments have made Telemis the leading player in Belgium. In Italy, the Istituto Nazionale Tumori, Fondazione Pascale, also chose to work with TM-Microscopy.
PACS/MACS: Continued Growth
Traditional imaging management solutions made a significant contribution to the year's results. New projects deployed across all countries contributed to a 41% growth in new projects. In France, as part of the second wave of the Ségur du Numérique en Santé, Telemis is developing its own “DRIMbox,” with the first installations scheduled for deployment in the coming year.
Additionally, in response to the increasing challenges of cyberattacks, Telemis is focused on supporting its clients, helping them better protect their systems and quickly restore them in the event of an incident.
INTUITUS: Business Intelligence Gaining Ground
Lastly, the Intuitus healthcare business intelligence solution continues to gain traction, with 16% growth for the group. The number of equipped sites in Belgium is constantly increasing, and adoption is beginning in other countries.
The Laboratory module was particularly highlighted this year, offering benefits in terms of traceability, compliance, and resource optimization. The ADMED laboratories in Neuchâtel, Switzerland, were deployed this year. Telemis also brought together experts and professionals this year at its Round Table on laboratory optimization. It was an enriching event marked by a presentation from the Brussels University Hospital Laboratory (LHUB).
The Radio and DACS (Dose Archiving and Communication System) modules are also experiencing strong growth across all territories. Finally, Telemis developed a financial Intuitus module that enables the implementation of billing indicators (e.g., incorrect encoding, completed exams with missing invoices).
Stephane Ketelaer, CEO of the Telemis group, expressed his satisfaction with this year's results, stating, “This year is marked by the growth of our three product lines in all the countries where Telemis operates. The arrival of Whitestone Group as a new shareholder also brings enhanced external growth opportunities.”